Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when NOVT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNovanta raises $300M in private placement, selling 2.1M shares at $140 to institutions
Filed June 9, 2026 · Period ending June 8, 2026 · ~1 min read
Key Changes
-
high
Company selling 2,142,857 common shares at $140/share to institutional investors for $300M gross proceeds, expected to close June 11, 2026. This represents significant capital infusion for the company.
Item 1.01 verify on EDGAR → -
high
Private placement will dilute existing shareholders by approximately 6%, increasing shares outstanding from 35.6M to 42.5M (including minimum Tangible Equity Unit settlements).
Item 1.01 verify on EDGAR → -
medium
New investors granted registration rights requiring Novanta to file registration statement within 30 days of closing and make effective within 45 days, enabling public resale of shares.
Item 1.01 verify on EDGAR → -
low
Four placement agents engaged (J.P. Morgan, William Blair, CJS Securities, PNC Capital Markets) with customary fees to be paid, reducing net proceeds from $300M gross amount.
Item 1.01 verify on EDGAR →
Summary
Novanta announced a $300 million private placement of common stock to institutional investors, pricing 2.1 million shares at $140 each. The transaction is expected to close June 11, 2026, subject to customary conditions.
This represents a significant capital raise that will dilute existing shareholders by approximately 6%, increasing total shares outstanding from 35.6 million to 42.5 million when including shares issuable from existing Tangible Equity Units. Retail investors should note that while the capital infusion strengthens Novanta's balance sheet, the dilution reduces existing shareholders' ownership percentage.
Additionally, the company granted registration rights requiring it to register these shares for public resale within 75 days of closing, which could create selling pressure once effective. Watch for the company's disclosure of how it intends to use the $300 million in proceeds, which was not specified in this filing. The intended use will determine whether this dilution creates offsetting value through growth investments, debt reduction, or acquisitions.
Section-by-Section Diff
Event · Item 1.01 — Entry into a Material Definitive Agreement
Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Also on June 8, 2026, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers, which provides that the Company will register the resale of the Common Shares sold by the Company in the Private Placement. The Company is required to prepare and file a registration statement with the Securities and Exchange Commission no later than 30 days after the date of the Closing, and to use its reasonable best efforts to have the registration statement declared effective within 45 days thereafter, subject to certain exceptions.
Novanta granted the private placement investors registration rights, requiring the company to file a registration statement within 30 days of closing and make best efforts to have it declared effective within 45 days. This will allow the new investors to resell their shares publicly, potentially creating selling pressure once the registration becomes effective.
Event · Item 3.02 — Unregistered Sales of Equity Securities
Novanta disclosed unregistered sales of equity securities, with details incorporated by reference from Item 1.01.
Added in current filing · verify on EDGAR →
Item 3.02 Unregistered Sales of Equity Securities
The information contained in Item 1.01 01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.
The company disclosed unregistered sales of equity securities under Item 3.02. The specific details of these sales are referenced in Item 1.01 of the same 8-K filing, which was not provided in the excerpt. Unregistered equity sales typically involve private placements or other exempt transactions that do not require SEC registration.
Event · Item 8.01 — Other Events
Novanta announced pricing of a private placement of common shares, with registration rights and expected proceeds disclosed in a press release.
Added in current filing · verify on EDGAR →
On June 9, 2026, the Company issued a press release announcing the pricing of the Private Placement described in Item 1.01 of this Current Report on Form 8-K.
Novanta disclosed that it priced a private placement of common shares on June 9, 2026. The details of this private placement are referenced in Item 1.01 of the same 8-K filing and announced via press release. This represents a capital-raising transaction that will affect the company's share count and capital structure.
Added in current filing · verify on EDGAR →
the Company’s agreement to register the Common Shares sold in the Private Placement
The company has agreed to register the common shares sold in the private placement with the SEC. This registration commitment means the shares will become freely tradable once registered, which could affect future share liquidity and potential dilution for existing shareholders.
Event · Item 9.01 — Financial Statements and Exhibits
Novanta entered into securities purchase agreements with investors on June 8, 2026, issuing securities with registration rights.
Added in current filing · verify on EDGAR →
Form of Securities Purchase Agreement, dated June 8, 2026, by and between Novanta Inc. and each purchaser thereto.
Novanta executed securities purchase agreements with one or more investors on June 8, 2026. The specific terms, pricing, and amount of securities sold are not disclosed in the 8-K body itself, though a press release is referenced. This represents a capital-raising transaction that may dilute existing shareholders or alter the company's capital structure.
Added in current filing · verify on EDGAR →
Form of Registration Rights Agreement, dated June 8, 2026, by and between Novanta Inc. and the other parties thereto.
Novanta granted registration rights to the purchasers of the securities, obligating the company to register the securities for resale under the Securities Act. This typically means the investors can sell their shares publicly after registration, which could increase future selling pressure on the stock.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify